Citrus aurantium for cholesterol management -
Citrus aurantium was chosen based on ethnopharmacological data because traditional medicine refers to the Citrus genus as useful in diminishing the symptoms of anxiety or insomnia, and C. aurantium has more recently been proposed as an adjuvant for antidepressants.
In the present work, we investigated the biological activity underlying the anxiolytic and antidepressant effects of C.
aurantium essential oil EO , the putative mechanism of the anxiolytic-like effect, and the neurochemical changes in specific brain structures of mice after acute treatment. We also monitored the mice for possible signs of toxicity after a day treatment.
More specifically, the use of hesperidin, a flavonoid compound abundantly occurring in Citrus family fruit peel, has been found to lower serum TG levels in hypertriglyceridemic subjects, possibly by reducing very low-density lipoprotein metabolic abnormalities In another study, conducted with the use of Citrus extracts and olive polyphenols, in relation to the lipid profile, there was a significant improvement in the serum levels of TC and LDL Due to the key antioxidant and anti-inflammatory effects of the plant extracts used in the composition of the nutritional supplement used herein along with vitamins B and chromium, a significant decrease in the TG levels was achieved.
The main limitation of the present study was that the findings were obtained from a small group of individuals, as well as in its short duration. The results attained in the present study, even if these are derived from a small sample size, establish a tendency.
Although the findings, particularly the suppressive effect on TG levels, appear promising, further larger studies for this nutritional supplement are required. Additionally, possible genetic profiling studies, related to the metabolism of TGs are required to further elucidate the regulatory mechanisms and the individual response after the use of a personalized intervention.
Funding: The present study was funded by the National and Kapodistrian University of Athens research grands research grant no. ND and SB conceived the study. DK and CPT performed the patient medical examinations.
EK, AT, SB and ND were involved in the acquisition of data, in the design of the study, and in the writing of the manuscript. VE performed the statistical analyses.
All authors have read and approved the final manuscript. AT and VE confirm the authenticity of all the raw data. The other authors declare that they have no competing interests. Rader DJ, Hoeg JM and Brewer HB Jr: Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease.
Ann Intern Med. Kopin L and Lowenstein CJ: Dyslipidemia. Berberich AJ and Hegele RA: A modern approach to dyslipidemia. Endocr Rev. Mascarenhas-Melo F, Sereno J, Teixeira-Lemos E, Marado D, Palavra F, Pinto R, Rocha-Pereira P, Teixeira F and Reis F: Implication of Low HDL-c levels in patients with average LDL-c Levels: A focus on oxidized LDL, Large HDL subpopulation, and adiponectin.
Mediators Inflamm. Khatana C, Saini NK, Chakrabarti S, Saini V, Sharma A, Saini RV and Saini AK: Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis.
Oxid Med Cell Longev. Pei K, Gui T, Kan D, Feng H, Jin Y, Yang Y, Zhang Q, Du Z, Gai Z, Wu J and Li Y: An overview of lipid metabolism and nonalcoholic fatty liver disease. BioMed Res Int. Tarantino G, Balsano C, Santini SJ, Brienza G, Clemente I, Cosimini B and Sinatti G: It is high time physicians thought of natural products for alleviating NAFLD.
Is there sufficient evidence to use them? Int J Mol Sci. Tarantino G, Crocetto F, Di Vito C, Creta M, Martino R, Pandolfo SD, Pesce S, Napolitano L, Capone D and Imbimbo C: Association of NAFLD and insulin resistance with non metastatic bladder cancer patients: A cross-sectional retrospective study.
J Clin Med. Chou R, Dana T, Blazina I, Daeges M and Jeanne TL: Statins for prevention of cardiovascular disease in adults: Evidence report and systematic review for the US preventive services task force. Farnier M, Zeller M, Masson D and Cottin Y: Triglycerides and risk of atherosclerotic cardiovascular disease: An update.
Arch Cardiovasc Dis. Tenenbaum A and Fisman EZ: Fibrates are an essential part of modern anti-dyslipidemic arsenal: Spotlight on atherogenic dyslipidemia and residual risk reduction. Cardiovasc Diabetol. Nordestgaard BG: Triglyceride-Rich lipoproteins and atherosclerotic cardiovascular disease: New insights from epidemiology, genetics, and biology.
Circ Res. Sando KR and Knight M: Nonstatin therapies for management of dyslipidemia: A review. Clin Ther. Widmer RJ, Flammer AJ, Lerman LO and Lerman A: The mediterranean diet, its components, and cardiovascular disease.
Am J Med. Medina-Remón A, Casas R, Tressserra-Rimbau A, Ros E, Martínez-González MA, Fitó M, Corella D, Salas-Salvadó J, Lamuela-Raventos RM and Estruch R: PREDIMED Study Investigators.
Polyphenol intake from a Mediterranean diet decreases inflammatory biomarkers related to atherosclerosis: A substudy of the PREDIMED trial. Br J Clin Pharmacol. Annuzzi G, Bozzetto L, Costabile G, Giacco R, Mangione A, Anniballi G, Vitale M, Vetrani C, Cipriano P, Della Corte G, et al: Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: A randomized controlled trial.
Am J Clin Nutr. Mazidi M, Katsiki N and Banach M: A greater flavonoid intake is associated with lower total and cause-specific mortality: A meta-analysis of cohort studies.
Kuchta A, Konopacka A, Waleron K, Viapiana A, Wesołowski M, Dąbkowski K, Ćwiklińska A, Mickiewicz A, Śledzińska A, Wieczorek E, et al: The effect of Cistus incanus herbal tea supplementation on oxidative stress markers and lipid profile in healthy adults.
Cardiol J. Victoria-Montesinos D, Abellán Ruiz MS, Luque Rubia AJ, Guillén Martínez D, Pérez-Piñero S, Sánchez Macarro M, García-Muñoz AM, Cánovas García F, Castillo Sánchez J and López-Román FJ: Effectiveness of consumption of a combination of citrus fruit flavonoids and olive leaf polyphenols to reduce oxidation of low-density lipoprotein in treatment-naïve cardiovascular risk subjects: A randomized double-blind controlled study.
Antioxidants Basel. Merola N, Castillo J, Benavente-García O, Ros G and Nieto G: The effect of consumption of citrus fruit and olive leaf extract on lipid metabolism. Raposeiras-Roubin S, Rosselló X, Oliva B, Fernández-Friera L, Mendiguren JM, Andrés V, Bueno H, Sanz J, Martínez de Vega V, Abu-Assi E, et al: Triglycerides and residual atherosclerotic risk.
J Am Coll Cardiol. Schwartz GG, Abt M, Bao W, DeMicco D, Kallend D, Miller M, Mundl H and Olsson AG: Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins. Holmes MV, Asselbergs FW, Palmer TM, Drenos F, Lanktree MB, Nelson CP, Dale CE, Padmanabhan S, Finan C, Swerdlow DI, et al: Mendelian randomization of blood lipids for coronary heart disease.
Eur Heart J. Marston NA, Giugliano RP, Im K, Silverman MG, O'Donoghue ML, Wiviott SD, Ference BA and Sabatine MS: Association between triglyceride lowering and reduction of cardiovascular risk across multiple lipid-lowering therapeutic classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials.
Nordestgaard BG and Varbo A: Triglycerides and cardiovascular disease. Varbo A, Benn M, Tybjærg-Hansen A, Jørgensen AB, Frikke-Schmidt R and Nordestgaard BG: Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease.
Nazir S, Jankowski V, Bender G, Zewinger S, Rye KA and van der Vorst EPC: Interaction between high-density lipoproteins and inflammation: Function matters more than concentration! Adv Drug Deliv Rev. O'Hagan R, Berg AR, Hong CG, Parel PM, Mehta NN and Teague HL: Systemic consequences of abnormal cholesterol handling: Interdependent pathways of inflammation and dyslipidemia.
Front Immunol. Aggarwal G, May-Zhang LS, Yermalitsky V, Dikalov S, Voynov MA, Amarnath V, Kon V, Linton MF, Vickers KC and Davies SS: Myeloperoxidase-induced modification of HDL by isolevuglandins inhibits paraoxonase-1 activity.
J Biol Chem. Meneses MJ, Silvestre R, Sousa-Lima I and Macedo MP: Paraoxonase-1 as a regulator of glucose and lipid homeostasis: Impact on the onset and progression of metabolic disorders. Kudinov VA, Alekseeva OY, Torkhovskaya TI, Baskaev KK, Artyushev RI, Saburina IN and Markin SS: High-Density lipoproteins as homeostatic nanoparticles of blood plasma.
Falchi A, Paolini J, Desjobert JM, Melis A, Costa J and Varesi L: Phylogeography of Cistus creticus L. on Corsica and Sardinia inferred by the TRNL-F and RPLTRNL sequences of cpDNA. Mol Phylogenet Evol. Cyboran-Mikołajczyk S, Pasławski R, Pasławska U, Nowak K, Płóciennik M, Męczarska K, Oszmiański J, Bonarska-Kujawa D, Kowalczyk P and Wawrzyńska M: Comparison of osmotic resistance, shape and transmembrane potential of erythrocytes collected from healthy and fed with high fat-carbohydrates diet HF-CD pigs-protective effect of Cistus incanus L.
The researchers said CA might directly suppress adipogenesis of white adipocytes and regulate thermogenesis of brown adipocytes which were both attractive targets of anti-obese strategy.
Adipocyte differentiation or adipogenesis is the process by which pre-adipocytes become adipocytes lipocytes or fat cells. The paper also reported that CA could regulate thermogenesis of brown adipocytes.
According to the researchers, brown fat specialise in energy expenditure to reduce weight gain through thermogenesis heat producing. Also known as sour orange or marmalade orange, CA is available on the market as a beverage and dietary supplement. Show more. Content provided by Gencor May Product Brochure.
Scientists from Korea have manabement bitter orange Managemsnt in Korean to mice fed a high-fat diet to study it as a fir therapeutic target Pomegranate health benefits obesity Citrs. The weight of the aurantiuk were measured twice a Plant-based meal options, and blood Citrus aurantium for cholesterol management taken to measure HDL, Mahagement, and total cholesterol. The researchers said CA might directly suppress adipogenesis of white adipocytes and regulate thermogenesis of brown adipocytes which were both attractive targets of anti-obese strategy. Adipocyte differentiation or adipogenesis is the process by which pre-adipocytes become adipocytes lipocytes or fat cells. The paper also reported that CA could regulate thermogenesis of brown adipocytes. According to the researchers, brown fat specialise in energy expenditure to reduce weight gain through thermogenesis heat producing. Also known as sour orange or marmalade orange, CA is available on the market as a beverage and dietary supplement. Background: The current Citrus aurantium for cholesterol management manageent anxiety disorders and depression have Citrus aurantium for cholesterol management adverse fr in addition to a delayed onset of manageement, which has prompted efforts to find new managemenh with Maagement activity in these Herbal remedy for fatigue. Citrus cjolesterol was chosen based cholestterol ethnopharmacological Dextrose Physical Performance because traditional medicine refers to the Citrus genus as useful managemennt diminishing the symptoms of anxiety or insomnia, and C. aurantium has more recently been proposed as an adjuvant for antidepressants. In the present work, we investigated the biological activity underlying the anxiolytic and antidepressant effects of C. aurantium essential oil EOthe putative mechanism of the anxiolytic-like effect, and the neurochemical changes in specific brain structures of mice after acute treatment. We also monitored the mice for possible signs of toxicity after a day treatment. Flumazenil, a competitive antagonist of benzodiazepine binding, and the selective 5-HT 1A receptor antagonist WAY were used in the experimental procedures to determine the mechanism of action of the EO.
Gerade, was notwendig ist. Das interessante Thema, ich werde teilnehmen.
die nützliche Information